50 research outputs found
Hepatocyte growth factor incorporated chitosan nanoparticles augment the differentiation of stem cell into hepatocytes for the recovery of liver cirrhosis in mice
<p>Abstract</p> <p>Background</p> <p>Short half-life and low levels of growth factors in the niche of injured microenvironment necessitates the exogenous and sustainable delivery of growth factors along with stem cells to augment the regeneration of injured tissues.</p> <p>Methods</p> <p>Here, recombinant human hepatocyte growth factor (HGF) was incorporated into chitosan nanoparticles (CNP) by ionic gelation method and studied for its morphological and physiological characteristics. Cirrhotic mice received either hematopoietic stem cells (HSC) or mesenchymal stemcells (MSC) with or without HGF incorporated chitosan nanoparticles (HGF-CNP) and saline as control. Biochemical, histological, immunostaining and gene expression assays were carried out using serum and liver tissue samples. One way analysis of variance was used for statics application</p> <p>Results</p> <p>Serum levels of selected liver protein and enzymes were significantly increased in the combination of MSC and HGF-CNP (MSC+HGF-CNP) treated group. Immunopositive staining for albumin (Alb) and cytokeratin 18 (CK18), and reverse transcription-polymerase chain reaction (RT-PCR) for Alb, alpha fetoprotein (AFP), CK18, cytokeratin 19 (CK19) ascertained that MSC-HGF-CNP treatment could be an effective combination to repopulate liver parenchymal cells in the liver cirrhosis. Zymogram and western blotting for matrix metalloproteinases 2 and 9 (MMP2 and MMP9) revealed that MMP2 actively involved in the fibrolysis of cirrhotic tissue. Immunostaining for alpha smooth muscle actin (αSMA) and type I collagen showed decreased expression in the MSC+HGF-CNP treatment. These results indicated that HGF-CNP enhanced the differentiation of stem cells into hepatocytes and supported the reversal of fibrolysis of extracellular matrix (ECM).</p> <p>Conclusion</p> <p>Bone marrow stem cells were isolated, characterized and transplanted in mice model. Biodegradable biopolymeric nanoparticles were prepared with the pleotrophic protein molecule and it worked well for the differentiation of stem cells, especially mesenchymal phenotypic cells. Transplantation of bone marrow MSC in combination with HGF-CNP could be an ideal approach for the treatment of liver cirrhosis.</p
Media Sosial dan Impak kepada Perkembangan Bahasa Menurut Islam
Media sosial merupakan salah satu teknologi komunikasi yang merupakan keperluan dalam kehidupan seharian masyarakat pada abad ini. Media sosial memainkan peranan yang sangat besar dalam kehidupan kita. Penggunaan media sosial dalam pelbagai aspek kehidupan memberi impak yang besar kepada perkembangan bahasa. Perkembangan bahasa merujuk kepada penguasaan sesuatu bahasa. Hakikatnya, media sosial memberi kesan yang besar kepada perkembangan bahasa sama ada kesan baik ataupun kesan buruk. Antara kesan positif ialah penguasaan lebih daripada satu bahasa, penggunaan bahasa pengantar yang berbeza, pengukuhan kosa kata adalah antara impak positif media sosial. Namun begitu, media sosial juga memberi kesan buruk terhadap perkembangan bahasa. Antaranya. penggunaan bahasa rojak, penggunaan bahasa kasar, dan menggugatkan akidah. Media sosial dapat menyumbang besar kepada perkembangan bahasa sekiranya tidak disalahgunakan
Nanoparticle-based bioactive agent release systems for bone and cartilage tissue engineering
The inability to deliver bioactive agents locally in a transient but sustained manner is one of the challenges on the development of bio-functionalized scaffolds for tissue engineering (TE) and regenerative medicine. The mode of release is especially relevant when the bioactive agent is a growth factor (GF), because the dose and the spatiotemporal release of such agents at the site of injury are crucial to achieve a successful outcome. Strategies that combine scaffolds and drug delivery systems have the potential to provide more effective tissue regeneration relative to current therapies. Nanoparticles (NPs) can protect the bioactive agents, control its profile, decrease the occurrence and severity of side effects and deliver the bioactive agent to the target cells maximizing its effect. Scaffolds containing NPs loaded with bioactive agents can be used for their local delivery, enabling site-specific pharmacological effects such as the induction of cell proliferation and differentiation, and, consequently, neo-tissue formation. This review aims to describe the concept of combining NPs with scaffolds, and the current efforts aiming to develop highly multi-functional bioactive agent release systems, with the emphasis on their application in TE of connective tissues.POLARIS (REGPOT-CT2012-316331-POLARIS), RL3 – TECT – NORTE-01-0124-FEDER-000020, co-financed by North Portugal Regional Operational Programme (ON.2 – O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF), the OsteoGraphy (PTDC/EME-MFE/2008) and MaxBone (PTDC/SAU-ENB/115179/2009) project
Mesenchymal stem cells: from experiment to clinic
There is currently much interest in adult mesenchymal stem cells (MSCs) and their ability to differentiate into other cell types, and to partake in the anatomy and physiology of remote organs. It is now clear these cells may be purified from several organs in the body besides bone marrow. MSCs take part in wound healing by contributing to myofibroblast and possibly fibroblast populations, and may be involved in epithelial tissue regeneration in certain organs, although this remains more controversial. In this review, we examine the ability of MSCs to modulate liver, kidney, heart and intestinal repair, and we update their opposing qualities of being less immunogenic and therefore tolerated in a transplant situation, yet being able to contribute to xenograft models of human tumour formation in other contexts. However, such observations have not been replicated in the clinic. Recent studies showing the clinical safety of MSC in several pathologies are discussed. The possible opposing powers of MSC need careful understanding and control if their clinical potential is to be realised with long-term safety for patients
Antioxidant and Anti-Inflammatory Action of Stem Cells in Cardiac Disease
Cardiac diseases are the consequence of blockage of blood vessels, scar formation and ultimate loss of terminally differentiated cardiomyocytes. Immune cells and oxidative stress easily slow down the cardiac functions by manipulating the cardiac tissue matrix. Stem cell-based therapies, especially mesenchymal stem cells (MSCs), multipotential nonhematopoietic progenitor cells compensate the cardiac diseases by differentiating into multiple lineages of mesenchyme including cardiomyocytes and vascular endothelial cells. Antioxidant and anti-inflammatory action of MSCs has been explored recently by various research groups. Secretion of biomolecules by MSCs perturbs and prevents the initiation, development and the function of the inflammatory cascade. These molecules mainly act through Paracrine mode. Anti-inflammatory action of MSCs mediates the cardiac diseases and the current progress in elucidating the mechanism and clinical use will be focused in detail in this article
Hepatocyte growth factor incorporated chitosan nanoparticles differentiate murine bone marrow mesenchymal stem cell into hepatocytes in vitro
Delivery of growth factor for the differentiation of stem cells into lineage specific cells holds great potential in regenerative medicine. Stem cell differentiation is governed by cytokines and growth factors secreted upon the organelle injury and, however, their short half-life necessitates exogenous supply. Development of suitable nanodevices using biodegradable polymers to deliver therapeutic proteins to the targeted site in a sustainable manner attracts scientists and clinicians. Here, for the first time, hepatocyte growth factor (HGF) was incorporated into chitosan nanoparticles (CNP) by ionotrophic gelation method. An average size of nanoparticles prepared was 100 nm, showing sustainable release of HGF. Cytotoxicity study did not reveal any adverse effect on bone marrow mesenchymal stem cells (MSC) up to 4 mg CNP/ml culture medium. To evaluate the effect of HGF incorporated CNP (HGF-CNP) on hepatic differentiation in in vitro, MSC were incubated with HGF-CNP and other supplements. After 21 days, fibroblast-like morphology of MSC became round-shape, a typical characteristic of hepatocyte cell. Immunofluorescence study for albumin expression confirmed the hepatic differentiation. In conclusion, HGF released from the HGF-CNP can differentiate MSC into hepatocytes, and this novel technique could also be extended to deliver therapeutic proteins for a variety of tissue regeneration
Arjunolic acid: A novel phytomedicine with multifunctional therapeutic applications
238-247Herbal plants with antioxidant activities
are widely used in Ayurvedic medicine for cardiac and other problems. Arjunolic
acid is one such novel phytomedicine with multifunctional therapeutic
applications. It is a triterpenoid saponin, isolated earlier from Terminalia arjuna and later from Combretum nelsonii, Leandra chaeton etc.
Arjunolic acid is a potent antioxidant and free radical scavenger. The
scientific basis for the use of arjunolic acid as cardiotonic in Ayurvedic
medicine is proven by its vibrant functions such as prevention of myocardial
necrosis, platelet aggregation and coagulation and lowering of blood pressure,
heart rate and cholesterol levels. Its antioxidant property combined with metal
chelating property protects organs from metal and drug induced toxicity. It
also plays an effective role in exerting protection against both type I and
type II diabetes and also ameliorates diabetic renal dysfunctions. Its
therapeutic multifunctionality is shown by its wound healing, antimutagenic and
antimicrobial activity. The mechanism of cytoprotection conferred by arjunolic
acid can be explained by its property to reduce the oxidative stress by
enhancing the antioxidant levels. Apart from its pathophysiological functions,
it possesses dynamic insecticidal property and it is used as a structural
molecular framework in supramolecular chemistry and nanoscience. Esters of
arjunolic acid function as gelators of a wide variety of organic liquids.
Experimental studies demonstrate the versatile effects of arjunolic acid, but
still, further investigations are necessary to identify the functional groups
responsible for its multivarious effects and to study the molecular mechanisms
as well as the probable side effects/toxicity owing to its long-term use. Though
the beneficial role of this triterpenoid has been assessed from various angles,
a comprehensive review of its effects on biochemistry and organ pathophysiology
is lacking and this forms the rationale of this review
Chitosan nanoparticles as a dual growth factor delivery system for tissue engineering applications
Sustainable delivery of therapeutic as well as functional proteins is largely required in the pharmacological and regenerative medicine. Here we have prepared chitosan nanoparticles (CNP) and incorporated growth factors such as epidermal growth factor (EGF) and fibroblast growth factor (FGF), either individually or in combination, which could ultimately be impregnated into engineered tissue construct. CNP was characterized by Fourier transform infrared (FTIR) spectroscopy, Zeta sizer and high resolution transmission electron microscope (HRTEM). The particles were in the size range of 50-100 nm with round and flat shape. The release kinetics of both EGF and FGF incorporated CNP showed the release of growth factors in a sustained manner. Growth factors incorporated nanoparticles did not show any toxicity against fibroblasts up to 4 mg/ml culture medium. Increased proliferation of fibroblasts in vitro evidenced the delivery of growth factors from CNP for cellular signaling. Western blotting results also revealed the poor inflammatory response showing less expression of proinflammatory cytokines such as IL-6 and TNFα in the macrophage cell line J774 A-1
Production of Neutrophil Extracellular Traps Contributes to the Pathogenesis of Francisella tularemia
10.3389/fimmu.2020.00679Frontiers in Immunology1167